Putting the “bio” in “biotherapeutics”/checkpoints for biosimilars/application of biosimilars

Juan V. Esplugues1, Bruno Flamion2, Lluis Puig3
1Department of Pharmacology, University of Valencia/CIBERehd, Blasco Ibañez, 15, 46010 Spain
2Department of Physiology and Pharmacology, University of Namur, 61 rue de Bruxelles, 5000 Namur Belgium
3Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Sant Quintí, 89, 08041 Barcelona, Spain